Literature DB >> 21618426

Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption.

Roman Lang1, Anika Wahl, Timo Stark, Thomas Hofmann.   

Abstract

SCOPE: In order to validate the in vivo function of putatively healthy molecules in foods, human intervention studies are required. As the subject's compliance concerning intake or abstinence of a given food is considered mandatory to be monitored by biomarkers, the objective was to identify analytical markers for coffee consumption. METHODS AND
RESULTS: Urine samples collected from coffee drinkers were compared with those of non-coffee drinkers using hydrophilic liquid interaction chromatography (HILIC)/time-of-flight mass spectrometry-based metabolite profiling. Two urinary molecules, found to be contributing most to the dissimilarities between both groups, were identified as N-methylpyridinium (NMP) and trigonelline and their suitability as coffee-specific biomarkers was validated by means of a coffee intervention study. After the volunteers (five females and four males) consumed a single dose of coffee, morning urine was collected for 10 days while staying abstinent from any coffee. HILIC-MS/MS-stable isotope dilution analysis (SIDA) revealed elevated urinary concentrations of trigonelline and NMP for up to 48 (p=0.001) and 72 h (p=0.002), respectively, after coffee consumption when compared with non-coffee drinkers.
CONCLUSION: Analysis of urinary NMP allows to check for coffee consumption within a period of 3 days and is proposed as a dietary biomarker which might be used as an analytical probe to control compliance in human intervention studies on coffee.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618426     DOI: 10.1002/mnfr.201000656

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  20 in total

1.  Nutritional metabolomics and breast cancer risk in a prospective study.

Authors:  Mary C Playdon; Regina G Ziegler; Joshua N Sampson; Rachael Stolzenberg-Solomon; Henry J Thompson; Melinda L Irwin; Susan T Mayne; Robert N Hoover; Steven C Moore
Journal:  Am J Clin Nutr       Date:  2017-06-28       Impact factor: 7.045

2.  Consumption of a dark roast coffee decreases the level of spontaneous DNA strand breaks: a randomized controlled trial.

Authors:  T Bakuradze; R Lang; T Hofmann; G Eisenbrand; D Schipp; J Galan; E Richling
Journal:  Eur J Nutr       Date:  2014-04-17       Impact factor: 5.614

3.  Coffee and cigarettes: Modulation of high and low sensitivity α4β2 nicotinic acetylcholine receptors by n-MP, a biomarker of coffee consumption.

Authors:  Roger L Papke; Madison Karaffa; Nicole A Horenstein; Clare Stokes
Journal:  Neuropharmacology       Date:  2022-06-27       Impact factor: 5.273

4.  Consumption of a dark roast coffee blend reduces DNA damage in humans: results from a 4-week randomised controlled study.

Authors:  Dorothea Schipp; Jana Tulinska; Maria Sustrova; Aurelia Liskova; Viera Spustova; Miroslava Lehotska Mikusova; Zora Krivosikova; Katarina Rausova; Andrew Collins; Vaineta Vebraite; Katarina Volkovova; Eva Rollerova; Magdalena Barancokova; Sergey Shaposhnikov
Journal:  Eur J Nutr       Date:  2018-11-17       Impact factor: 5.614

5.  Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial.

Authors:  Kerstin Kempf; Hubert Kolb; Babette Gärtner; Gerhard Bytof; Herbert Stiebitz; Ingo Lantz; Roman Lang; Thomas Hofmann; Stephan Martin
Journal:  Eur J Nutr       Date:  2014-09-10       Impact factor: 5.614

6.  Urinary metabolic signatures of human adiposity.

Authors:  Paul Elliott; Joram M Posma; Queenie Chan; Isabel Garcia-Perez; Anisha Wijeyesekera; Magda Bictash; Timothy M D Ebbels; Hirotsugu Ueshima; Liancheng Zhao; Linda van Horn; Martha Daviglus; Jeremiah Stamler; Elaine Holmes; Jeremy K Nicholson
Journal:  Sci Transl Med       Date:  2015-04-29       Impact factor: 17.956

7.  New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjects.

Authors:  Joseph A Rothwell; Yoann Fillâtre; Jean-François Martin; Bernard Lyan; Estelle Pujos-Guillot; Leopold Fezeu; Serge Hercberg; Blandine Comte; Pilar Galan; Mathilde Touvier; Claudine Manach
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

8.  Assessment of metabolic phenotypic variability in children's urine using 1H NMR spectroscopy.

Authors:  Léa Maitre; Chung-Ho E Lau; Esther Vizcaino; Oliver Robinson; Maribel Casas; Alexandros P Siskos; Elizabeth J Want; Toby Athersuch; Remy Slama; Martine Vrijheid; Hector C Keun; Muireann Coen
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

Review 9.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

10.  Effects of Trigonelline, an Alkaloid Present in Coffee, on Diabetes-Induced Disorders in the Rat Skeletal System.

Authors:  Joanna Folwarczna; Aleksandra Janas; Maria Pytlik; Urszula Cegieła; Leszek Śliwiński; Zora Krivošíková; Kornélia Štefíková; Martin Gajdoš
Journal:  Nutrients       Date:  2016-03-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.